Bayer AG Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs

Published: Feb 28, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEVERKUSEN, Germany, Feb 28 (Reuters) - Germany's largest drugmaker Bayer lifted its estimate for potential sales of new drugs by billions of euros on Friday, softening the blow of a fall in fourth-quarter earnings.

Adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) in the last three months of 2013 slipped to 1.77 billion euros, dampened by a weak Japanese yen and emerging-market currencies, the company said, missing the 1.91 billion euro average estimate in a Reuters poll.

Help employers find you! Check out all the jobs and post your resume.

Back to news